Oravig miconazole: Phase I started

Sosei began an open-label, crossover, Japanese Phase I trial to evaluate 50 and 100 mg SO-1105 in healthy volunteers. Last May, BioAlliance granted Sosei exclusive rights in Japan to develop and comme...